生命科學產品市場:各產品類型，各用途，各終端用戶，各地區-市場規模，佔有率，展望，機會分析，2023～2030年

Life Science Products Market, By Product (Recombinant Proteins, Cell Lines, Antibodies, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月20日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

市場參與者也專注於進行臨床試驗以擴大其產品組合，此外，擴大採用合作夥伴關係等無機增長戰略預計將在預測期內推動市場增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球生命科學產品市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球生命科學產品市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球生命科學產品市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球生命科學產品市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Life science, also referred to as biology, is the study of life and living things. It includes anatomy, animal biology, bacteriology, biochemistry, cell biology, ecology, evolutionary biology, genetics, molecular biology, plant biology, physiology, and virology. Life science plays a major role in drug discovery, tissue engineering, drug screening, forensic testing, and genetic analysis. The life sciences industry consists of companies operating in the fields of pharmaceuticals, biotechnology, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and others that dedicate their efforts to creating products to improve the lives of organisms. Life sciences products, including reagents, assays, antibodies, immunoassays, and more. Dedicated Fisher Scientific life sciences specialists are ready to help you find the research products and supplies you need for your molecular biology, cell biology, and protein purification. Life Sciences cater to the research and discovery of living organisms and include areas of study such as Agricultural and Biological Sciences, Immunology, and Neuroscience.

Market Dynamics

Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in March 2020, Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, presented additional analyses from the ORCA-1 Phase 2b trial that assessed the efficacy of 'Cytisinicline', a plant-based alkaloid with a high binding affinity to the α4B2 nicotine receptor, at the SRNT Annual Meeting in New Orleans. Moreover, an increase in the adoption of inorganic growth strategies such as partnerships is expected to drive the growth of the market over the forecast period. For instance, in October 2021, Leinco Technologies, Inc., a contract development manufacturing organization (CDMO), and Vanderbilt University, based in U.S., announced a partnership that will give Leinco exclusive rights to increase antibody production at the center for infectious disease clinical research, diagnostics, therapeutics, and vaccine development.

Key features of the study:

This report provides an in-depth analysis of the global life science products market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global life science products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc, Crown Bioscience Inc., Genscript Biotech Corporation, Merck Millipore Limited, PerkinElmer Inc, Sigma Aldrich Corp, Thermo Fisher Scientific Inc., Danaher Corporation, Amgen Inc, Lantern Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global life science products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life science products market

Detailed Segmentation:

Global Life Science Products Market, By Product Type:
- Recombinant Proteins
  - Immune Checkpoint Regulators
  - Chemokines
  - Growth Factors
  - Cytokines
  - Colony Stimulating Factors
  - Hormones
  - Enzymes & Inhibitors
  - Others
- Cell Lines
  - Immunotherapy Cell Lines
  - Ion Channel Cell Lines
  - GPCR Cell Lines
  - Cell Signaling Pathway Cell Lines
  - Gene Knockout Cell Lines
  - Cancer Cell Lines
  - Others
- Antibodies
  - Immune Checkpoint Antibodies
  - Epitope Tag Antibodies
  - Isotype Control Antibodies
- Research Use
- In-vivo Grade
  - Primary Antibodies
- Research Use
- In-vivo Grade
  - Assay Antibodies (includes secondary antibodies)
- Others
Global Life Science Products Market, By Application:
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
Global Life Science Products Market, By End User:
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Diagnostic Centers
- Others
Global Life Science Products Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Abcam Plc*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- M.S. Biotechnology (Europe) Limited
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc
- Crown Bioscience Inc.
- Genscript Biotech Corporation
- Merck Millipore Limited
- PerkinElmer Inc
- Sigma Aldrich Corp
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Amgen Inc
- Lantern Pharma Inc

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Life Science Products Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Life Science Products Market, By Product Type, 2018-2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
- Cell Lines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Others
- Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Immune Checkpoint Antibodies
- Epitope Tag Antibodies
- Isotype Control Antibodies
Research Use
In-vivo Grade
- Primary Antibodies
Research Use
In-vivo Grade
- Assay Antibodies (includes secondary antibodies)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Life Science Products Market, By Application, 2018-2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Basic Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Toxicity Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Biopharmaceutical Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Drug Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Forensic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Life Science Products Market, By End User, 2018-2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Forensic Science Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Life Science Products Market, By Region, 2018-2030, (US$ Million)

Overview
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type,2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application,2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Abcam Plc*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
M.S. Biotechnology (Europe) Limited
Bio-Rad Laboratories Inc.
BPS Bioscience Inc
Crown Bioscience Inc.
Genscript Biotech Corporation
Merck Millipore Limited
PerkinElmer Inc
Sigma Aldrich Corp
Thermo Fisher Scientific Inc.
Danaher Corporation
Amgen Inc
Lantern Pharma Inc